I think your take is very reasonable and youve given a fair assessment. That said, I do reckon 4DX is in a better spot than most early-stage med-techs on the ASX. Most of the core products are FDA and TGA cleared and the tech is already being used and/or trialed in some top-tier U.S. academic hospitals. That’s not something many small caps can say at this stage. When you compare 4DX to other small caps that are still stuck in trial phases 5+ years after listing (EMV comes to mind), 4DX is clearly further ahead in terms of commercial progress.
They’ve already got contracts in place with major radiology groups across almost every state in Australia, as well as Philips partnerships in the U.S where the ball has just started rolling. The key thing is that the tech works, contracts are there, and now we’re all just waiting on revenue to ramp up. Sure, expectations are high and the big question now is whether Philips partnership can help drive serious revenue growth in the next 6 months or so and we don't have to wait very long to find out.
As always said 4DX is a high-risk high-reward play and for investors in that category, I honestly don’t see many other ASX small caps with the same kind of potential. That’s just my opinion, and good luck to all holders out there.
- Forums
- ASX - By Stock
- Ann: Quarterly Activity Report and Appendix 4C for Q3 FY2025
4DX
4dmedical limited
Add to My Watchlist
0.00%
!
26.5¢

I think your take is very reasonable and youve given a fair...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
26.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $123.3M |
Open | High | Low | Value | Volume |
26.5¢ | 26.5¢ | 26.0¢ | $199.2K | 753.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 498142 | 26.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.5¢ | 18283 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 498142 | 0.260 |
13 | 164995 | 0.255 |
30 | 1195385 | 0.250 |
10 | 109400 | 0.245 |
7 | 276000 | 0.240 |
Price($) | Vol. | No. |
---|---|---|
0.265 | 18283 | 1 |
0.270 | 105687 | 4 |
0.275 | 54970 | 4 |
0.280 | 100712 | 6 |
0.285 | 106871 | 4 |
Last trade - 12.32pm 18/06/2025 (20 minute delay) ? |
Featured News
4DX (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
SPONSORED BY The Market Online